CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Stock

Certificat

DE000VU13FY1

Market Closed - Deutsche Boerse AG 14:01:30 2024-07-05 EDT
6.58 EUR +3.95% Intraday chart for CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+5.96%
1 month-32.99%
Date Price Change
24-07-05 6.58 +3.95%
24-07-04 6.33 +4.46%
24-07-03 6.06 -1.46%
24-07-02 6.15 -3.30%
24-07-01 6.36 +2.42%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 02:01 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU13FY
ISINDE000VU13FY1
Date issued 2023-01-11
Strike 29.64
Maturity Unlimited
Parity 1 : 1
Emission price 4.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 21.1
Lowest since issue 1.83

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus